Home / Telehealth Consulting
Lower overhead and a wider reach, with the system our team has used to launch hundreds of clinics.
Book Your Strategy CallFree 30-minute call · No obligation
Not a lesser version or a workaround: the same system behind our brick-and-mortar clinic launch, on virtual infrastructure.
Patients already look for care online: U.S. searches for “online TRT” run 1,000 to 10,000 a month (Google Keyword Planner).
Our team has structured the common cash-pay telehealth categories virtually: an online TRT clinic, a medical weight loss clinic on FDA-approved GLP-1s, and peptide therapy on what is lawful to compound.
Commodity telehealth brands win on price. A premium practice wins the patient who wants a real clinical relationship, and that is the business ACG helps you build. The telehealth clinic business model lays out the full picture.
Google Keyword Planner, U.S., Sep 2025 to Aug 2026, in the ranges Google reports. Category searches, not telehealth alone.
Telehealth rules have changed repeatedly since 2020. Here is where they stand in October 2026.
Medicine is practiced where the patient is located during the visit, so clinicians generally need a license in each patient's state. The Interstate Medical Licensure Compact speeds that up for physicians in its 44 member states.
Federal law generally requires an in-person medical evaluation before a controlled substance is prescribed remotely. Testosterone is Schedule III, so online TRT depends on DEA's rules for controlled substance prescribing via telehealth.
A temporary DEA and HHS rule lifts that requirement for Schedule II to V medications, when its conditions are met, through December 31, 2026. DEA's permanent special registration rule is in final review, not yet published. ACG plans your prescribing for both outcomes.
Nurse practitioner authority varies by state: full, reduced or restricted practice. ACG works with partner Medical Director networks that cover all 50 states.
Current as of October 2026. Confirm with your Medical Director and qualified counsel; this is not legal or medical advice.
Websites and marketing execution are separate engagements.
Not sure which model fits? Compare the 13 clinic types by patient demand, or ask on the 30-minute strategy call.
Straight answers on licensing, prescribing and Medical Directors. Anything else, ask on the strategy call.
View All FAQs
Talk with Grayson Miller about the states you want to serve, your service menu and the prescribing rules for 2027. No pitch. No obligation.
ACG is a consulting and advisory firm, not a medical practice; an independent, state-licensed Medical Director directs all clinical care. Results are not guarantees of income. Individual outcomes vary. The 60-day launch is a target, market and regulatory conditions permitting.
Knowing the rules is the foundation of every clinic we help launch.
You own and run the business. An independent, state-licensed Medical Director makes every clinical, prescribing and treatment decision, structured for your state's Corporate Practice of Medicine laws. We connect you to a vetted network; you retain your own provider.
PRP, peptides, GLP-1 medications and cellular products each carry federal and state rules, and not every product or use is FDA-approved. Exosomes for therapeutic use are not FDA-approved at all, and we steer you away from them. Your menu and marketing are built to hold up to FDA, FTC and state medical board scrutiny.
We show real ranges and never promise an income or a clinical outcome. What you earn depends on your market, your capital and your execution.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe or sell any drug, biologic, device or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the compliance of every product, therapy and claim. See the full regulatory notice below.